New results and forthcoming EORTC trials in prostate cancer, melanoma, head and neck, lung, rare, and breast cancers presented at ESMO 2024
17 Sep 2024
Seven IMMUcan abstracts selected for ESMO Immuno-Oncology Congress 2023
6 Dec 2023
New results and forthcoming EORTC trials in rare cancers, lung, head and neck, and breast carcinomas presented at ESMO 2023
20 Oct 2023
EORTC & the Menarini Group Launch New Clinical Trial in Early-Stage Breast Cancer
19 Oct 2023
EORTC’s presence at ESMO 2023
17 Oct 2023
EORTC, CTI, and IRROG collaboration opens new opportunities in Ireland
12 Dec 2022
Promising results for the ultra-low risk patient group in latest MINDACT analysis
27 Jan 2022
PRESS RELEASE: Sanofi partnering with leading academic cooperative groups to study amcenestrant in the adjuvant setting for patients with estrogen receptor positive breast cancer
4 Jun 2021